AHA furious over ruling to exclude ‘orphan’ drugs from 340B program


http://www.healthcarefinancenews.com/news/aha-furious-over-ruling-exclude-orphan-drugs-340b-program?mkt_tok=3RkMMJWWfF9wsRovu6%2FMZKXonjHpfsX57u4rUa6zlMI%2F0ER3fOvrPUfGjI4IRMFgI%2BSLDwEYGJlv6SgFQ7LHMbpszbgPUhM%3D

The ruling means pharmaceutical companies that make orphan drugs do not have to sell then to rural and cancer hospitals at a discount.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.